A Phase 1b Study of NC410 in Combination with Pembrolizumab in Immune Checkpoint Inhibitor (ICI) Naïve, and Refractory Microsatellite Stable (mss)/microsatellite Instability-Low (MSI-L) Colorectal Cancer (CRC) and Ovarian Cancer.
Journal of Clinical Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要